作者: Lien Moreels , Steve Peigneur , Diogo T Galan , Edwin De Pauw , Lászlo Béress
DOI: 10.3390/MD15090287
关键词:
摘要: The human ether-a-go-go channel (hEag1 or KV10.1) is a cancer-relevant voltage-gated potassium that overexpressed in majority of tumors. Peptides are able to selectively inhibit this can be lead compounds the search for new anticancer drugs. Here, we report activity-guided purification and electrophysiological characterization novel KV10.1 inhibitor from sea anemone Anthopleura elegantissima. Purified fractions were screened inhibitory activity on by measuring whole-cell currents as expressed Xenopus laevis oocytes using two-microelectrode voltage clamp technique. Fractions showed Kv10.1 further purified RP-HPLC. amino acid sequence peptide was determined combination MALDI- LIFT-TOF/TOF MS/MS CID-ESI-FT-ICR high similarity with APETx1 APETx3 therefore named APETx4. Subsequently, electrophysiologically characterized KV10.1. selectivity toxin investigated an array ion channels, including cardiac ether-a-go-go-related gene (hERG Kv11.1). inhibits IC50 value 1.1 μM. In presence similar concentration, shift activation curve towards more positive potentials observed. Similar effect gating modifier hERG, inhibition isolated reduced at voltages seems keep closed state. Although also induces effects other KV NaV it exhibits no significant hERG. Moreover, APETx4 concentration-dependent cytotoxic proapoptotic various cancerous noncancerous cell lines. This newly identified used tool characterize oncogenic scaffold design synthesis potent safer